Walgreens Boots Alliance (WBA, Financial) experienced a notable stock surge, climbing 5.02% to reach $9.53 per share. The trading volume stood at approximately 10.28 million shares, with a turnover rate of 1.19% and a price fluctuation amplitude of 5.35%.
Recent financial reports reveal substantial figures: the company generated $147.66 billion in revenue, yet recorded a net loss of $8.636 billion, resulting in earnings per share (EPS) of -$10.01 and a gross profit of $24.065 billion. The current price-to-earnings ratio is -0.95.
Analyst ratings show mixed opinions with 20% recommending a buy, 60% suggesting a hold, and 20% advising a sell. The pharmaceutical retail industry, where Walgreens operates, saw a slight downturn of 0.01%.
In this sector, Walgreens, Scienture Holdings, Inc., and Petmed Express, Inc. exhibited significant gains. The stocks of High Tide Inc., Petmed Express, Inc., and Walgreens showed significant trading activity, with turnover rates of 1.69%, 1.30%, and 1.19% respectively. Notable amplitude in related stocks includes High Tide Inc. at 8.00%, Petmed Express, Inc. at 7.73%, and Scienture Holdings, Inc. at 6.80%.
As a leading retail pharmacy chain in the United States, Walgreens Boots Alliance operates over 8,000 stores. Nearly 75% of Americans live within five miles of a Walgreens location. Approximately two-thirds of its revenue is derived from prescription drug sales, contributing to 20% of the U.S. total prescription market. The company also profits from retail products, European pharmaceutical wholesale, and healthcare services. With initiatives like Health Corner and Village Medical, Walgreens is enhancing its comprehensive healthcare service offerings.
